Inovio Biomedical Corporation to Present at Roth Capital Partners Growth Stock Investor Conference
SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex:INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, President and CEO, will present at Roth Capital Partners’ 22nd Annual OC Growth Stock Conference on Monday, March 15th at 9:00 a.m. PT (12:00 noon ET). The conference is being held March 15-17, 2010, in Dana Point, California.